Browse > Article
http://dx.doi.org/10.18325/jkmr.2022.32.1.37

A Systematic Review of Acupuncture Treatment for Thromboangiitis Obliterans  

Choi, Ji Min (Department of Korean Medicine Rehabilitation, College of Korean Medicine, Dongshin University)
Jeon, Seok Hee (Department of Acupuncture and Moxibustion Medicine, Dongshin University Mokpo Korean Medicine Hospital)
Lim, Yong Ha (Department of Korean Medicine Rehabilitation, College of Korean Medicine, Dongshin University)
Jung, Min Jae (Department of Korean Medicine Rehabilitation, College of Korean Medicine, Dongshin University)
Kim, Seon Jong (Department of Korean Medicine Rehabilitation, College of Korean Medicine, Dongshin University)
Publication Information
Journal of Korean Medicine Rehabilitation / v.32, no.1, 2022 , pp. 37-49 More about this Journal
Abstract
Objectives The purpose of this study is to present evidence by analyzing the research trends in acupuncture treatment in the last 10 years for thromboangiitis obliterans. Methods Randomized controlled trials about acupuncture on thromboangiitis obliterans were searched China National Knowledge Infrastructure (CNKI), PubMed, EMBASE, Cochrane Library, Oriental Medicine Advanced Searching Integrated System (OASIS), ScienceON, Koreanstudies Information Service System (KISS) and Research Information Sharing Service (RISS) from January 1, 2011 to November 13, 2021. Only randomized controlled trials were selected and we assessed the risk of bias (RoB) according to the revised Cochrane RoB2 criteria. Results A total of 5 randomized controlled trials (RCTs) were selected in this review and all were conducted in China. A total of 326 participants were in 5 RCTs. SP10, ST36, GB34 was the most commonly used treatment point. There were four types of acupuncture used: manual acupuncture, embedding acupuncture, pharmacopuncture, electroacupuncture. The most commonly used indicator for evaluation was the total efficacy rate, and all five studies were significantly higher. Conclusions All selected studies showed the group treated with acupuncture treatments on thromboangiitis obliterans were statistically more effective than the control group. However, the number of studies is too small and the interpretation of the results is limited due to the inclusion of subjective evaluation. So more objective and systematic studies should be conducted continuously.
Keywords
Thromboangiitis obliterans; Acupuncture; Randomized controlled trial; Systematic review;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Yu XX. Injection of salvia miltiorrhoza and ligustrazine acupoint injection therapy for the treatment of thromboangiitis obliterans [dissertation]. Harbin:Heilongjiang University of Chinese Medicine; 2018.
2 Shin ES, Kim HJ, Kim JS, Son ES, Yu YM. Comparison of clinical efficacy and safety between aspirin and sarpogrelate in patients with arteriosclerosis obliterans. Journal of Korean Society of Health-System Pharmacists. 2020;37(2):190-9.   DOI
3 Er KJ, Go YS. A literatural study on the Tal-Juh. The Journal of Oriental Medical Surgery, Ophthalmology & Otolaryngology. 1997;10(1):306-31.
4 Kang H. Statistical considerations in meta-analysis. Hanyang Medical Reviews. 2015;35:23-32.   DOI
5 Li C, Luo G. Clinical efficacy of acupuncture combined with oral Chinese medicine in the treatment of thromboangiitis obliterans pain. Journal of Vascular and Endovascular Surgery. 2018;4(6):518-21.
6 Zhang Z, Ji J, Zhang D, Ma M, Sun L. Protective effects and potential mechanism of salvianolic acid B on sodium laurate-induced thromboangiitis obliterans in rats. Phytomedicine. 2020;66:153110.   DOI
7 Lawrence PF, Lund OI, Jimenez JC, Muttalib R. Substitution of smoke less tobacco for cigarettes in Buerger's disease does not prevent limb loss. Journal of Vascular Surgery. 2008;48(1):210-2.   DOI
8 Eom JY, Chae JS, Ko TH, Son SS, Choi IS. Case of ulcer resulting from buerger's disease improve by acupuncture therapy. The Journal of Korean Acupuncture & Moxibustion Society. 2004;21(4):263-8.
9 Lee HS, Cha SJ, Park HJ, Seo JC, Park JB, Lee HJ, Hue MP, Douglas GA, Richard H, Li YP, Wu TX, Adrian W, David M, on behalf of the STRICTA Revision Group. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. Korean Journal of Acupuncture. 2010;27(3):1-23.
10 Zheng X, Liu H, Ma M, Ji J, Zhu F, Sun L. Anti-thrombotic activity of phenolic acids obtained from Salvia miltiorrhiza f. alba in TNF-α-stimulated endothelial cells via the NF-κB/JNK/p38 MAPK signaling pathway. Archives of Pharmacal Research. 2021;44:427-38.   DOI
11 Xu Z, Lu W, Jiang R, Hou B, Deng L, Kuang L, Kuang Z, He Z, Wang J. Observation on the clinical effect of acupuncture around the greater tuberosity of femur combined with acupuncture at Xuehai point to relieve postoperative pain of elderly patients with intertrochanteric fracture of femur. Guizhou University of Traditional Chinese Medicine. 2020;29(2):241-4.
12 Kwak BM, Hong KE. Case of buerger's disease improve by Gi-Chim treatment (leech therapy). Journal of Pharmacopuncture. 2009;12(2):91-8.   DOI
13 Nalluri H, Amishek K, Mohammed AA. Buerger's disease: a segmental nonatherosclerotic inflammatory disorder. International Journal of Pharmaceuticals and Health Care Research. 2015;3(3):79-83.
14 The Korean Orthopaedic Association. Orthopaedics. 8th ed. Seoul:ChoiSin medical Publishing. 2020:748-9.
15 Korea Centers for Disease Control and Prevention. National Health and Nutrition Survey FACT SHEET: Changes in health behaviors and chronic diseases over 20 years (1998-2018) [Internet] 2020 [cited 2021 Nov 27]. Available from: URL: https://knhanes.cdc.go.kr/knhanes/sub04/sub04_04.do.
16 Health Insurance Review & Assessment. Disease subdivision (fourth tier of morbidity) statistics [Internet] 2021 [cited 2021 Nov 26]. Available from: URL: http://opendata.hira.or.kr/op/opc/olap4thDsInfo.do.
17 Lee HJ, Lee BY, Lee YE, Yang SB, Cho SY, Park JM, Ko CN, Park SU. Raynaud phenomenon due to Buerger's disease: a case report. The Journal of Internal Korean Medicine. 2015;36(3):427-35.
18 Li YH, Cao HQ. Clinical study on acupuncture plus nerve blocking for thromboangiitis obliterans. Shanghai Journal of Acupuncture and Moxibustion. 2014;33(7):627-8.   DOI
19 Sterne JA, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hernan MA, Hopewell S, Hrobjartsson A, Junqueira DR, Juni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JP. RoB 2: a revised tool for assessing risk of bias in randomized trials. British Medical Journal. 2019;366:1-8.
20 Gao J, Duan JH, Li J. Influence of acupoint embedding therapy on clinical efficacy of thromboangiitis obliterans. Journal of Hebei TCM and Pharmacology. 2021;36(2):30-4.
21 Shionoya S. Diagnostic criteria of Buerger's disease. International Journal of Cardiology. 1998;66:243-5.   DOI
22 Zhang Q. Clinical studies of adjuvant therapy electric Jiaji stage I thrombosis obliterans [dissertation]. Harbin: Heilongjiang University of Chinese Medicine; 2014.
23 Kang AR, Hyun SH, Woo JM, Kim YS, Cho KH, Moon SK, Jung WS. A case study of a thromboangiitis obliterans (Buerger's disease) patient with lower extremity pain and claudication treated by traditional Korean medicine. The Journal of Internal Korean Medicine. 2014;35:271-5.
24 Im JG, Lee HG, Jung DJ, Yook TH, Kim JU. A comparative study of the effects between mountain-burning fire method and heaven-penetrating cooling method at Zusanli (ST36) on thermographic change. The Journal of Korean Acupuncture & Moxibustion Society. 2012;29(2):1-8.
25 McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Research Synthesis Methods. 2021;12(1):55-61.   DOI
26 Park KH, Choi YJ. Medical management of peripheral arterial disease. Korean J Lipidol. 2011;21:46-60.
27 Choi SH. Current management of peripheral arterial disease. Journal of the Korean Medical Association. 2010;53(3):228-35.   DOI
28 Cacione DG, do Carmo Novaes F, Moreno DH. Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease). Cochrane Database Syst Rev. 2018;10:CD012794.
29 Gavrilenko AV, Oleinik EM. Comprehensive treatment of a patient with Buerger's disease using genetically engineered complexes VEGF-165. Angiol Sosud Khir. 2019;25(1):177-80.   DOI
30 Jeong JJ, Sun SH, Lee YH, Go HY, Jung KY, Song YK, Kim TH, Hong SI, Choi YK, Go SG, Lim EM, Park JH, Jeon CY. Literature review on syndrome differentiation and herbal medicine of thromboangiitis obliterans -focusing on traditional Chinese medicine's journals-. Journal of Physiology & Pathology in Korean Medicine. 2015;29(2):143-51.   DOI
31 Editorial Committee. Neo intern handbook. 2nd ed. Paju:Koonja Publishing. 2016:506-8.